Evidence map›Paper›PMID 27544543›Full record

ArticleJournal of pharmacological and toxicological methods

Characterization of GABA

Nina Y Yuan, Michael M Poe, Christopher Witzigmann, James M Cook, Douglas Stafford, Leggy A Arnold

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmacological and toxicological methods. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nina Y YuanDepartment of Chemistry and Biochemistry and Milwaukee Institute for Drug Discovery, University of Wisconsin - Milwaukee, 3210 N. Cramer Street, Milwaukee, WI 53211, United States. Electronic address: ninayuan@uwm.edu.
Michael M PoeDepartment of Chemistry and Biochemistry and Milwaukee Institute for Drug Discovery, University of Wisconsin - Milwaukee, 3210 N. Cramer Street, Milwaukee, WI 53211, United States. Electronic address: mmpoe@uwm.edu.
Christopher WitzigmannDepartment of Chemistry and Biochemistry and Milwaukee Institute for Drug Discovery, University of Wisconsin - Milwaukee, 3210 N. Cramer Street, Milwaukee, WI 53211, United States. Electronic address: witzigm2@uwm.edu.
James M CookDepartment of Chemistry and Biochemistry and Milwaukee Institute for Drug Discovery, University of Wisconsin - Milwaukee, 3210 N. Cramer Street, Milwaukee, WI 53211, United States. Electronic address: capncook@uwm.edu.
Douglas StaffordDepartment of Chemistry and Biochemistry and Milwaukee Institute for Drug Discovery, University of Wisconsin - Milwaukee, 3210 N. Cramer Street, Milwaukee, WI 53211, United States. Electronic address: dcstaff@uwm.edu.
Leggy A ArnoldDepartment of Chemistry and Biochemistry and Milwaukee Institute for Drug Discovery, University of Wisconsin - Milwaukee, 3210 N. Cramer Street, Milwaukee, WI 53211, United States. Electronic address: arnold2@uwm.edu.
University of Wisconsin–Milwaukee · US

Funding

Development of new drugs for asthma by targeting GABA(A) receptors in the lungR01HL118561 · NHLBI · UNIVERSITY OF WISCONSIN MILWAUKEE · PI COOK, JAMES M · 2014 to 2017
$2.0M
Design of New Therapeutic Agents to Treat SchizophreniaR01MH096463 · NIMH · UNIVERSITY OF WISCONSIN MILWAUKEE · PI COOK, JAMES M · 2013 to 2017
$1.9M
Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic PainR01NS076517 · NINDS · UNIVERSITY OF WISCONSIN MILWAUKEE · PI COOK, JAMES M · 2012 to 2015
$1.3M
Small molecule inhibitors of the vitamin D receptor-coactivator interactionR03DA031090 · NIDA · UNIVERSITY OF WISCONSIN MILWAUKEE · PI ARNOLD, ALEXANDER · 2010 to 2011
$73k
NHLBI NIH HHS R01 HL118561NIDA NIH HHS R03 DA031090NIMH NIH HHS R01 MH096463NINDS NIH HHS R01 NS076517
6 · The paper itself

Abstract

introductionAutomated patch clamp is a recent but widely used technology to assess pre-clinical drug safety. With the availability of human neurons derived from pluripotent stem cells, this technology can be extended to determine CNS effects of drug candidates, especially those acting on the GABA

methodsiCell Neurons (Cellular Dynamics International, A Fujifilm Company) were cultured for ten days and analyzed by patch clamp in the presence of agonist GABA or in combination with positive allosteric GABA

resultsWe have shown that iCell Neurons are compatible with the IonFlux microfluidic system of the automated patch clamp instrument. Resistance ranging from 15 to 25MΩ was achieved for each trap channel of patch clamped cells in a 96-well plate format. GABA induced a robust change of current with an EC DISCUSSION: iCell Neurons represent a new cellular model to characterize GABAergic compounds using automated patch clamp. These cells have excellent representation of cellular GABA

Indexed as

Allosteric RegulationCell Culture TechniquesCells, CulturedGABA-A Receptor AgonistsHumansLigandsMembrane PotentialsNeuronsPatch-Clamp TechniquesPluripotent Stem CellsProtein SubunitsReceptors, GABA-AGABA-A Receptor AgonistsLigandsProtein SubunitsReceptors, GABA-ACW-04-020DiazepamGABAGABA(A) receptorHuman-induced pluripotent stem cellHZ-166iCell neuronIonfluxPatch clamp

Identifiers

PMID27544543
PMCPMC5116268
OpenAlexW2516962605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.